Complications of pelvic radiation in patients treated for gynecologic malignancies

AN Viswanathan, LJ Lee, JR Eswara, NS Horowitz… - Cancer, 2014 - Wiley Online Library
Radiation therapy is a critical treatment modality in the management of patients with
gynecologic tumors. New highly conformal external‐beam and brachytherapy techniques …

[HTML][HTML] Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with …

A Corbeau, SC Kuipers, SM de Boer… - Radiotherapy and …, 2021 - Elsevier
Patients with locally advanced cervical cancer (LACC) treated with chemoradiation often
experience hematologic toxicity (HT), as chemoradiation can induce bone marrow (BM) …

Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective …

AK Gandhi, DN Sharma, GK Rath, PK Julka… - International Journal of …, 2013 - Elsevier
Purpose To evaluate the toxicity and clinical outcome in patients with locally advanced
cervical cancer (LACC) treated with whole pelvic conventional radiation therapy (WP-CRT) …

Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer

AH Klopp, J Moughan, L Portelance, BE Miller… - International Journal of …, 2013 - Elsevier
PURPOSE: Intensity modulated radiation therapy (IMRT), compared with conventional 4-
field treatment, can reduce the volume of bone marrow irradiated. Pelvic bone marrow …

Bone marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for stage IB-IVA cervical cancer: an international multicenter phase II clinical trial …

LK Mell, I Sirák, L Wei, R Tarnawski… - International Journal of …, 2017 - Elsevier
Purpose To test the hypothesis that intensity modulated radiation therapy (IMRT) reduces
acute hematologic and gastrointestinal (GI) toxicity for patients with locoregionally advanced …

Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix

MD Hasselle, BS Rose, JD Kochanski, SK Nath… - International Journal of …, 2011 - Elsevier
PURPOSE: To evaluate disease outcomes and toxicity in cervical cancer patients treated
with pelvic intensity-modulated radiation therapy (IMRT). METHODS AND MATERIALS: We …

Highly efficient training, refinement, and validation of a knowledge-based planning quality-control system for radiation therapy clinical trials

N Li, R Carmona, I Sirak, L Kasaova, D Followill… - International Journal of …, 2017 - Elsevier
Purpose To demonstrate an efficient method for training and validation of a knowledge-
based planning (KBP) system as a radiation therapy clinical trial plan quality-control system …

Advances in radiation oncology for the treatment of cervical cancer

MD Faye, J Alfieri - Current Oncology, 2022 - mdpi.com
Background: Over the past two decades, there has been significant advancement in the
management of cervical cancer, particularly in the domain of definitive chemoradiotherapy …

Correlation between radiation dose to 18F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with …

BS Rose, Y Liang, SK Lau, LG Jensen… - International Journal of …, 2012 - Elsevier
PURPOSE: To test the hypothesis that radiation dose to 18F-fluorodeoxyglucose positron
emission tomography (18F-FDG-PET)-defined active bone marrow (BMACT) subregions is …

Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies

Y Liang, M Bydder, CM Yashar, BS Rose… - International Journal of …, 2013 - Elsevier
PURPOSE: To test the hypothesis that intensity modulated radiation therapy (IMRT) can
reduce radiation dose to functional bone marrow (BM) in patients with pelvic malignancies …